Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Clinical trial NCT03587662 · COMPLETED

Trial details

NCT number: NCT03587662
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Kidney Medullary Carcinoma Metastatic Renal Cell Carcinoma SMARCB1 Negative Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8

Start date: 2018-08-17
Primary completion: 2026-08-04
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.